Ophthalmic Drugs Market Registering A CAGR Of 4.5% For The Forecast Period From 2019 To 2026 : Grand View Research Inc.
San Francisco, 27 June 2019: The Report Ophthalmic Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Disease (Retinal Disorder, Allergies), By Dosage Form (Eye Drops, Eye Solutions), By Product Type, And Segment Forecasts, 2019 – 2026 The global ophthalmic drugs market size is expected to reach USD 43.1 billion by 2026 registering a CAGR of 4.5%, according to a new report by Grand View Research, Inc. Increased funding by public and private bodies for conducting research on ocular disorders and presence of strong emerging pipeline drugs are some of the factors responsible for the growth of ophthalmic therapeutics market. For instance, Shire and Parion Sciences collaborated to develop and commercialize P-321, which will be used in the treatment of dry eye diseases in adults. In addition, approval of novel products for the treatment of eye disorders is expected to propel the market. For instance, in 2017, Nicox, received FDA approval of ZERVIATE (cetirizin